The Cartagena Protocol on Biosafety that was adopted by governments on 29 January 2000 is the main international legally binding treaty that regulates ?the safe transfer, handling and use of living modified organisms resulting from modern biotechnology? that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health?.

It is significant as the first global treaty to attempt to contribute to the protection of biodiversity and human health in this field, and as the first treaty to operationalise the precautionary approach in decision-making relating to imports under the Protocol. As of 22 February 2005, there are 113 Parties to the Protocol.

Although the Protocol focuses on transboundary movements of GMOs, its provisions do influence national and regional biosafety policies and laws, bearing in mind that the Protocol sets minimum requirements and Parties have the right to formulate more comprehensive national laws with higher standards. This is reaffirmed in Article 2(4).

Meanwhile, work and standard setting are also taking place in other international fora, such as the Codex Alimentarius, the International Plant Protection Convention and the International Office of Epizootics, the UN Food and Agriculture Organisation and the World Health Organisation.

The linkages among trade, environment and health means that developments at the World Trade Organisation also impact on biosafety and vice versa.

A field of growing importance is the development of biological weapons as part of biodefence programmes where the adequacy of global rules and standards needs examinination.

Calls for Precaution on “Gene Drives” at Biodiversity Meeting

Parties to the Convention on Biological Diversity (CBD), at a subsidiary meeting, have called for precaution when addressing organisms containing engineered gene drives. […]

Reboot on GMO Risk Assessment Work Under Biosafety Protocol

Parties to the Cartagena Protocol on Biosafety, at a subsidiary meeting in Montreal, have breathed some life back into the risk assessment work that is critical to the implementation of the Protocol. […]

Informational Materials on Synthetic Biology and Sequence Information

New informational materials about the important emerging area of synthetic biology and associated topic of digital sequence information on genetic resources are now available at www.synbiogovernance.org […]

Military Revealed as Top Funder of Gene Drives; Gates Foundation Paid $1.6 million to Influence UN on Gene Drives

Over 1,200 emails released under open records requests reveal that the US military is now the top funder and influencer behind a controversial genetic extinction technology known as “gene drives”. […]

Plant Treaty to Address Genetic Sequence Information

The International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA) has decided to begin serious work on the subject of sequence information of crop genetic resources. […]

Sequence Information: A Pressing Concern for the Seed Treaty

Sequence information is a topic that governments cannot afford to ignore at the 7th meeting of the Governing Body (GB) of the International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA) in November 2017 in Kigali, Rwanda. […]

Biosafety Protocol Stalled on Risk Assessment

Further work on biosafety risk assessment which is a key pillar under the Cartagena Protocol on Biosafety has received a setback at the UN Biodiversity Conference […]

Biodiversity – Divergent views on progress towards resource mobilization targets

With the biodiversity financing gap remaining huge, Parties to the CBD had divergent views on whether progress has been made to meet the targets set in 2012 for mobilizing financial resources. […]

Report of Scientific Conference Taking Stock – 20 Years of GM Crops – 40 Years of ‘Genetic Engineering’

The report of the recent Scientific Conference, Taking Stock – 20 years of GM crops – 40 years of ‘genetic engineering’, which was held in Mexico City, 1-2 December 2016. […]

Four Steps Forward, One Leap Back on Global Governance of Synthetic Biology

Parties to the CBD have made progress in the global governance and oversight of synthetic biology. However, progress on risk assessment work under the Cartagena Protocol on Biosafety has stalled. […]